News
The prevalence of obesity among young people in the UK represents a significant challenge within the field of public health.
A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...
A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...
A new study shows that people who develop type 1 diabetes in adulthood have an increased risk of cardiovascular disease and death, and that those diagnosed later in life do not have a better prognosis ...
The deal with U.S. biotech Septerna will see the companies develop pills to treat obesity, type 2 diabetes and other ...
A new nationwide analysis is shedding light on how states compare when it comes to a major public health challenge, and the ...
Explore more
Today, we're putting a super popular workout under the microscope: CrossFit. And we're tackling a big question: Is it the ...
Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.
Doctors generally have an easier time diagnosing type 1 diabetes in kids, who present with classic symptoms of excessive thirst, excessive urination, and weight loss. “Children often have a really ...
California is not required by federal law to cover the cost of the weight loss drugs in its Medi-Cal program. Instead, the state opted to include them. Under Newsom’s proposed cuts, when Ozempic is ...
GSK is acquiring an experimental medicine from a Cambridge biotech to shore up its drug pipeline and muscle into the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results